-
The Ministry of Education announces the enrollment plan for undergraduate clinical medicine students in China
Time of Update: 2021-04-13
2. Colleges and universities that are included in the list of undergraduate clinical medicine (English-taught) international students in China for the 2021-2022 academic year must continue to recruit students strictly in accordance with the spirit of the "Notice".
-
The National Health Commission issued the "New Coronavirus Vaccination Technical Guidelines"
Time of Update: 2021-04-13
Based on the clinical trial research data of my country's approved vaccines and the epidemiological characteristics of new coronary pneumonia, the New Coronavirus Vaccine Working Group of the Chinese Center for Disease Control and Prevention drafted this guide, which was reviewed and approved by the Expert Advisory Committee of the National Immunization Program.
-
Spanish expert: pregnant women vaccinated can help neonatal immunization
Time of Update: 2021-04-13
" Carbonello said that if this theory is correct, then in the future, as long as pregnant women are vaccinated with a new coronavirus vaccine that does not carry the virus, the newborns will be immune to protection at the same time.
-
The global cumulative number of confirmed cases of new crown reaches 131020967
Time of Update: 2021-04-13
The latest data from the WHO website shows that as of 16:19 on the 5th Central European Time (22:19 Beijing time), the number of confirmed cases worldwide increased by 561,783 compared with the previous day, reaching 131020967; the number of deaths increased by 8196, reaching 2850521 example.
-
Chinese experts have made new progress in the field of cerebral hemorrhage research
Time of Update: 2021-04-13
Li Qi, the first author of the paper and associate professor of the Department of Neurology at the First Affiliated Hospital of Chongqing Medical University, introduced that previous studies have shown that intensive antihypertensive treatment is not beneficial to control hematoma enlargement or improve the poor prognosis of patients.
-
7 people in the UK have died of blood clots after being vaccinated with AstraZeneca
Time of Update: 2021-04-13
Xinhua News Agency, London, April 3 (Reporter Zhang Jiawei Jin Jing) The British Broadcasting Corporation quoted the country’s Medicines and Health Products Administration on the 3rd, saying that seven people in the country have been vaccinated with the joint research and development of AstraZeneca Pharmaceuticals and Oxford University.
-
Circadian rhythm regulation mechanism of insulin sensitivity
Time of Update: 2021-03-30
Scientists reveal the circadian regulation mechanism of insulin sensitivity Scientists reveal the circadian regulation mechanism of insulin sensitivity Scientists reveal the circadi
-
Physiological regulation mechanism of "dawn phenomenon" in diabetic patients
Time of Update: 2021-03-30
According to reports, the study reveals the regulation mechanism of insulin sensitivity rhythm in glucose metabolism, not only explaining physiological phenomena, but also providing mechanism explanations and treatment suggestions for the "dawn phenomenon" that plagues diabetic patients.
-
The most compact superconducting cyclotron proton therapy system was successfully developed
Time of Update: 2021-03-30
Schematic diagram of the most compact domestically produced superconducting cyclotron proton therapy system (data picture) As a new type of radiotherapy technology, proton therapy has the advantages of good therapeutic effect, small side effects, and quick recovery of patients.
-
Health Commission: 9 new confirmed cases, all imported from abroad
Time of Update: 2021-03-30
The latest situation of the novel coronavirus pneumonia epidemic as of 24:00 on March 22 The latest situation of the novel coronavirus pneumonia epidemic as of 24:00 on March 22 The
-
Health Commission: 11 new confirmed cases, all imported from abroad
Time of Update: 2021-03-30
As of 24:00 on March 24, according to reports from 31 provinces (autonomous regions and municipalities) and the Xinjiang Production and Construction Corps, there are currently 165 confirmed cases (no severe cases), a total of 85,335 cured and discharged cases, and a total of 4,636 deaths.
-
U.S. research shows that children have stronger responses to new coronavirus antibodies than adults
Time of Update: 2021-03-30
The researchers narrowed the scope of the study to 85 children and 3648 adults who tested positive for the new crown, and further assessed their IgG antibody levels.
-
Delaying COVID-19 surgery for seven weeks can reduce the risk of death
Time of Update: 2021-03-30
China News Service, Hong Kong, March 23 (Reporter Han Xingtong) The Chinese University of Hong Kong (CUHK) announced on the 23rd that a joint study by CUHK and overseas surgical experts found that if a patient diagnosed with new coronary pneumonia undergoes surgery within six weeks after diagnosis, they will Increasing the risk of postoperative death, research suggests that the operation should be postponed to the seventh week or later after diagnosis.
-
One disease, one picture | The competitive landscape of clinical medications for Dravet syndrome
Time of Update: 2021-03-28
Dravet syndrome is a hereditary epileptic encephalopathy that begins in infants and young children, formerly known as infantile myoclonic epilepsy.
5% of all types of myoclonic epilepsy in children, and 8% of epilepsy in infants and young children under 3 years old.
-
Newest | These 20 best selling drugs
Time of Update: 2021-03-27
11Hospital market, Top 20 drugsHospital market, Top 20 drugsAccording to the full-year data information of the PDB (PDB) in 2020, affected by the new crown epidemic, the market sales of sample hospita
-
FDA extends the review period for supplementary new drug applications for AbbVie RINVOQ due to safety considerations
Time of Update: 2021-03-27
CompileLiLiOn March 17, according to foreign media reports, AbbVie announced that the US FDA has extended the review period for the anti-inflammatory drug RINVOQ Supplemental New Drug Application (sNDA) for the treatment of active psoriatic arthritis (PsA) in adults.
-
Five new drugs are planned to be breakthrough therapies from Junshi, Microchip, Novo Nordisk...
Time of Update: 2021-03-27
include:Junshi Biologics' PD-1 Teriprizumab is used in the first-line treatment of mucosal melanoma;Novo Nordisk's long-acting GLP-1 inhibitor Semaglutide (Semaglutide) is used in the treatment of NASH;The first class of Microchip's new drug Cioroni is used in the treatment of ovarian cancer;Yuheng Bio/WuXi Biologics PD-1 monoclonal antibody Sepalizumab (GLS-010) is used in the treatment of cervical cancer;Shanghai Ruixing's oxynidone capsule is used for chronic hepatitis B fibrosis.
-
Why is there little news about the gradual launch of new crown vaccines?
Time of Update: 2021-03-27
From the end of 2020 to the present for more than two months, a variety of new crown vaccines have been approved for marketing worldwide, and large-scale vaccination has begun in China, the United States, Russia, Brazil, Southeast Asia, the Middle East and other countries and regions for the global economy and society The restoration of order brought dawn.
-
Procon Health Technology and Hutchison Medical reach clinical cooperation
Time of Update: 2021-03-27
Source: Guanlan PharmaceuticalOn February 23, Convalife announced that it has reached a clinical cooperation with Hutchison Pharmaceuticals to evaluate the high selection of PARP inhibitors Mefurpiride and Hutchison Pharmaceuticals with "best-in-class" potential for approval for listing The safety and tolerability of Fruquintinib combined with the treatment of solid tumors.
-
The best pharmaceutical companies in the hearts of American employees: Horizon, Genentech, and AbbVie are among the top three
Time of Update: 2021-03-27
In this year's industry survey, GreatPlacetoWork compiled the annual ranking of Fortune by using an anonymous survey of more than 825,000 employees from the US medical and pharmaceutical industries.
"Reference source: Horizon, Roche's Genentech, AbbVie and Neurocrine rank as top pharma places to work in annual poll
